J. Sundelof

发表

In Vivo Activity and Pharmacokinetic Evaluation of a Novel Long-Acting Carbapenem Antibiotic, MK-826 (L-749,345)

B. Pelak, C. Gill, H. Rosen, 1998, Antimicrobial Agents and Chemotherapy.

Antibiotic sensitization using biphenyl tetrazoles as potent inhibitors of Bacteroides fragilis metallo-beta-lactamase.

D. Vanderwall, P. Fitzgerald, D. Pompliano, 1998, Chemistry & biology.

Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872)

H Kropp, B. Pelak, J. Dropinski, 1997, Antimicrobial agents and chemotherapy.

Urinary Recovery of N-Formimidoyl Thienamycin (MK0787) as Affected by Coadministration of N-Formimidoyl Thienamycin Dehydropeptidase Inhibitors

K. Alestig, S. Norrby, K. H. Jones, 1983, Antimicrobial Agents and Chemotherapy.

Metabolism of Thienamycin and Related Carbapenem Antibiotics by the Renal Dipeptidase, Dehydropeptidase-I

R. Hajdu, J. Sundelof, H. Kropp, 1982, Antimicrobial Agents and Chemotherapy.

Dicationic 2-fluorenonylcarbapenems: potent anti-MRS agents with improved solubility and pharmacokinetic properties.

M. Greenlee, M. Hammond, J. Huber, 1999, Bioorganic & medicinal chemistry letters.

Reduced immunotoxicity and preservation of antibacterial activity in a releasable side-chain carbapenem antibiotic.

H. Rosen, J. Heck, J. Kozarich, 1999, Science.

MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities

J. Birnbaum, J. Sundelof, H. Kropp, 1980, Antimicrobial Agents and Chemotherapy.

Thienamycin: development of imipenem-cilastatin

J. Birnbaum, J. Sundelof, H. Kropp, 1983 .

Antibacterial activity of imipenem: the first thienamycin antibiotic.

L. Gerckens, J. Sundelof, H. Kropp, 1985, Reviews of infectious diseases.

Pharmacokinetics of L-749,345, a long-acting carbapenem antibiotic, in primates

C. Gill, H. Rosen, R. Hajdu, 1997, Antimicrobial agents and chemotherapy.

Pharmacokinetics in nonhuman primates of a prototype carbapenem active against methicillin-resistant Staphylococcus aureus

J. Sundelof, H. Kropp, L. Cama, 1996, Antimicrobial agents and chemotherapy.

Benzothiazolylthio carbapenems: potent anti-MRSA agents

S. T. Waddell, R. Wilkening, K. J. Wildonger, 1995 .

Synthesis and properties of 2-(naphthosultamyl)methyl-carbapenems with potent anti-MRSA activity: discovery of L-786,392.

J. Heck, S. T. Waddell, R. Wilkening, 1999, Bioorganic & medicinal chemistry letters.

Pharmacokinetics of L-671,329 in rhesus monkeys and DBA/2 mice

W. Cleare, R. Hajdu, J. Sundelof, 1992, Antimicrobial Agents and Chemotherapy.

The synthesis and anti-MRSA activity of amidinium-substituted 2-dibenzofuranylcarbapenems.

M. Greenlee, J. Huber, J. Sundelof, 1999, Bioorganic & medicinal chemistry letters.

Aerosolization of imipenem/cilastatin prevents pseudomonas-induced acute lung injury.

B. Guglielmo, J. Pittet, S. Hashimoto, 1996, The Journal of antimicrobial chemotherapy.

Thienamycin: development of imipenen-cilastatin.

J. Birnbaum, J. Sundelof, H. Kropp, 1983, The Journal of antimicrobial chemotherapy.